PHAXIAM Therapeutics (PHXM) Stock Chart & Stock Price History → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free PHXM Stock Alerts $3.10 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends PHAXIAM Therapeutics Stock Price Performance5 Day PerformanceN/A1 Month PerformanceN/A3 Month Performance+8.77%6 Month Performance-22.50%Year-To-Date Performance-30.18% Receive PHXM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PHAXIAM Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide PHXM Stock Chart for Saturday, June, 1, 2024 PHXM Chart by TradingView PHAXIAM Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$3.10$3.10$3.10$3.05900 shs$10.58 million05/06/2024$3.10$3.10$3.10$3.05900 shs$10.58 million04/15/2024$3.10$3.10$3.10$3.05900 shs$10.58 million04/08/2024$3.10$3.10$3.10$3.05900 shs$10.58 million03/18/2024$3.10$3.10$3.10$3.05900 shs$10.58 million03/11/2024$3.10$3.10$3.10$3.05900 shs$10.57 million03/08/2024$3.12$3.10-0.64%$3.10$3.05902 shs$10.57 million03/07/2024$3.01$3.12+3.65%$3.29$3.011,850 shs$10.64 million03/06/2024$3.01$3.01$3.12$2.803,339 shs$10.26 million03/05/2024$2.50$3.01+20.40%$3.12$2.803,339 shs$10.27 million03/04/2024$2.81$2.50-11.03%$3.16$2.504,819 shs$8.53 million03/01/2024$2.85$2.81-1.40%$3.02$2.535,487 shs$9.58 million02/29/2024$2.98$2.85-4.36%$2.85$2.81184 shs$9.72 million Related Companies: Eyenovia Stock Chart LianBio Stock Chart RenovoRx Stock Chart Oncternal Therapeutics Stock Chart Sol-Gel Technologies Stock Chart Kaleido Biosciences Stock Chart Genprex Stock Chart Palisade Bio Stock Chart NexImmune Stock Chart Virios Therapeutics Stock Chart Receive PHXM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PHAXIAM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHXM) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsBiden Nomination CANCELED?The Freeport Society[Urgent!] Generational Wealth GameplanCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PHAXIAM Therapeutics S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.